DPHS Get To Know Us Booklet 09-30-19 by UM Department of Public Health Sciences

THIS IS A PUBLIC HEALTH

MOMENT

University of Miami Miller School of Medicine Department of Public Health Sciences

TABLE OF CONTENTS

University of Miami Miller School of Medicine Department of Public Health Sciences

ABOUT DPHS The Department of Public Health Sciences (DPHS) is located in the University of Miami Miller School of Medicine (UMMSM) and is organized into five divisions: Biostatistics, Epidemiology and Population Health Sciences, Health Services Research and Policy, Environment and Public Health, and Prevention Science and Community Health. Currently, there are 39.75 full-time faculty, 40 voluntary faculty, and 37 with secondary appointments.

MISSION Our mission is to discover strategies that promote health among people, families, communities and environments. We implement this mission in multicultural South Florida, the Americas and beyond, developing leaders who can expand knowledge and translate research into public health policy, practice and service for diverse populations.

RESEARCH DPHS is a leader in research, teaching, and service and is closely aligned with foundational public health values. Department faculty are collaboratively engaged in research across the medical school and the broader University community and currently ranks #8 in National Institutes of Health (NIH) funding within the UMMSM. The NIH funding ranking of DPHS is favorable relative to other U.S. Public Health Schools (27th out of 65) and departments within Medical Schools (19th out of 46). In 2018, DPHS had over 11 million dollars in NIH and other research funding across its divisions.

GRADUATE PROGRAMS

Public Health and Master of Science degrees in Biostatistics, Climate and Health, and Prevention Science and Community Health. We offer certificates and innovative joint degree programs, including our highly successful fouryear MD/MPH program. We also offer joint degrees in Medicine, Law, International Administration, Latin American Studies, and Public Administration. These programs have served as an effective bridge to the Coral Gables campus, which is located 12 miles from the medical campus. Students in the College of Arts and Sciencesâ&#x20AC;&#x2122; Master of Arts in Global Health & Society degree program also develop an interdisciplinary perspective on global health and may focus their studies on public health tools and methodologies by taking up to 12 MPH credits. Currently, DPHS faculty are leading the effort to develop and launch new MS programs in Applied Epidemiology and Environment & Public Health.

INTERNATIONAL, NATIONAL AND LOCAL IMPACT The research and service missions of DPHS are synergistically intertwined with its teaching mission. Many students embed within the research programs of DPHS faculty and faculty-supervised MPH Capstone projects have led to local, national and international placements in over 30 countries in the past two years alone. Student led service projects also impact the greater Miami area, as well as regional efforts in the Caribbean and elsewhere. DPHS faculty also serve as mentors on F30/F31 training grants awarded to DPHS students as well as for students and post-doctoral fellows on NIH T32 training programs across the University.

DPHS is an innovator in the training of the next generation of public health practitioners and scientists. Current enrollment exceeds 360 students across a range of masterâ&#x20AC;&#x2122;s and doctoral programs that are accredited under the Council on Education for Public Health (CEPH). These training programs include three doctoral degrees in Epidemiology, Biostatistics, and Prevention Science, as well as Master of Public Health (MPH), Master of Science in University of Miami Miller School of Medicine Department of Public Health Sciences

INNOVATIVE

DPHS brings sustainable, positive changes in health by providing an outstanding program of research, teaching and service â&#x20AC;&#x201C; to educate the next generation of public health leaders who endeavor to discover, test and disseminate solutions to health threats and problems; and translate research into effective practices and sound policies.

University of Miami Miller School of Medicine Department of Public Health Sciences

GLOBAL LEADERS

EXECUTIVE COMMITTEE ORGANIZATIONAL CHART J. Sunil Rao, Ph.D. Interim Chair Biostatistics Division Director J. Sunil Rao, Ph.D. Professor, Tenured

Margie Jimenez, M.A., CRA Assistant Chair Environment & Public Health Division Director John Beier, Sc.D. Professor, Tenured

Prevention Science & Community Health Division Director Guillermo “Willy” Prado, Ph.D. Professor, Tenured

Health Services Research & Policy Division Director Kathryn McCollister, Ph.D. Associate Professor, Tenured

Epidemiology & Population Health Sciences Division Director Hermes Florez, MD, MPH, Ph.D. Professor, Tenured

Graduate Programs Director David Lee, Ph.D. Professor, Tenured

MD/MPH Program Director Roderick King, MD, MPH Associate Professor, Educator

Public Health Education Director Viviana Horigian, MD, MHA Associate Professor, Educator

University of Miami Miller School of Medicine Department of Public Health Sciences

J. Sunil Rao, Ph.D.

Margie Jimenez, M.A., CRA

John Beier, Sc.D.

Guillermo “Willy” Prado, Ph.D.

David Lee, Ph.D. University of Miami Miller School of Medicine Department of Public Health Sciences

Kathryn McCollister, Ph.D.

Roderick King, MD, MPH

Hermes Florez, MD, MPH, Ph.D.

Viviana Horigian, MD, MHA 11

DEPARTMENT ORGANIZATIONAL CHART J. Sunil Rao, Ph.D. Professor & Interim Chair Department of Public Health Sciences

Margie Jimenez, M.A., CRA Assistant Chair

Environment & Public Health John Beier, Sc.D.

Biostatistics J. Sunil Rao, Ph.D. Professor, Tenured

Professor, Tenured Division Director Current Division FTE: 4

Division Director Current Division FTE: 12.75

Epidemiology & Population Health Sciences Hermes Florez, MD, MPH, Ph.D. Professor, Tenured Division Director Current Division FTE: 8

Hemant Ishwaran, Ph.D. Professor, Tenured Director of Biostatistics Ph.D. Program Director of Statistical

Daniel Feaster, Ph.D.

Naresh Kumar, Ph.D.

Scott Brown, Ph.D.

Associate Professor,

Research Associate

Tenured

Tenure Earning

Professor

David Lee, Ph.D. Jennifer Hu, Ph.D.

Professor, Tenured

Director of Graduate Programs

Methodology

Shari Messinger, Ph.D. Associate Professor,

Lily Wang, Ph.D.

Tenured

Associate Professor,

Director of Biostatistics

Tenured

Core

Alberto CabanMartinez, Ph.D., DO, MPH Assistant Professor, Tenure Earning

WayWay Hlaing, Ph.D.

TBA

Associate Professor,

Replacement

Educator

Approved

Director of Epidemiology

Assistant Professor,

Ph.D. Program

Tenure Earning

TBA Xi (Steven) Chen, Ph.D.

Replacement

Taghrid Asfar, MD, MSPH

Associate Professor,

Pending approval

Paulo Pinheiro, Ph.D.

Research Assistant

Tenured

Associate/Full Professor,

Research Associate

Professor

Tenured

Tulay Koru-Sengul, Ph.D. Research Associate Professor

Isildinha Reis, Ph.D.

Tali Elfassy, Ph.D., MSPH

Lead Faculty MSPH

Research Professor

Research Assistant Professor

Director of MS in Biostatistics Program

Daniel DiazPanchon, Ph.D.

Raymond Balise, Ph.D.

Research Assistant

Professor

.75 FTE

Deukwoo Kwon, Ph.D. Research Assistant Professor

University of Miami Miller School of Medicine Department of Public Health Sciences

Min Lu, Ph.D. Research Assistant Professor

FY17

Faculty FTE

Tenure: 18 Tenure Earning: 7 Research: 7 Educators: 6

Tenure: 17 Tenure Earning: 6 Research: 5 Educators: 6

Tenure: 16 Tenure Earning: 6 Research: 10.75 Educators: 5.0

FY18

FY19

Total: 38

Total: 34

Total: 39.75

* Includes 9 junior faculty

* Includes 8 junior faculty

* Includes13 junior faculty * Does not include 4 TBA hires

Health Services Research & Policy Kathryn McCollister, Ph.D.

Prevention Science & Community Health Guillermo “Willy” Prado, Ph.D.

Administration

Associate Professor, Tenured

Professor, Tenured

Division Director

Graduate Programs, Finance and Operations

Current Division FTE 8 *excluding Frenk & Knaul

Current Division FTE: 9

Julio Frenk, MD,

Felicia Knaul, Ph.D.

MPH, Ph.D.

Professor, Tenured

TBA

Seth Schwartz, Ph.D.

Graduate

Replacement

Professor, Tenured

Programs

Approved

Department IRB Role

Begoña Rovira, MBA

Associate Professor/

Director of Prevention

Professor, Tenured

Science Ph.D. Program

Adam Carrico, Ph.D.

Eric Brown, Ph.D.

Director of Accreditation

Associate Professor,

and Doctoral Programs

Executive Director, Programs

Finance Jessica Carbajal, MBA Director, Finance Laura Gutierrez, MBA Sr. Financial Analyst

Heather Rose, MPH

Howard Liddle, Ed.D.

Jose Szapocznik, Ph.D.

Professor, Tenured

Tenure Earning

Grand Rounds

Director of Prevention

Coordinator

Science MS Programs

Andria Williams, MBA Director, Admissions Rosa Verdeja, M.Ed.

Roderick King, MD, MPH

Viviana Horigian, MD, MHA

Associate Professor,

Educator

Director of MD/MPH

Director of Public Health

Program

Education Director Latin America

Director, Academic

Tatiana Perrino, Psy.D. Associate Professor, Educator Chair, Curriculum Committee MD/MPH

Affairs Sara St. George, Ph.D. Assistant Professor, Tenure Earning

Megan Garber, M.Ed. Associate Director, Career and Professional Development

and MPH

Carlen Duncombe, MPA Sr. Manager, Enrollment

TBA Replacement

Mariano Kanamori, Ph.D.

Assistant Professor,

Pending approval

Assistant Professor,

Educator

Associate Professor,

Tenure Earning

Adriane Gelpi, Ph.D., MPH

Research

Audrey Harkness, Ph.D.

Services

Research Assistant

Andrea Sparano, MPH

Professor

Manager, MD/MPH Capstone Program Barbara “Barbie” Galvez, MA Sr. Program Coordinator,

Grants Management Cinthia Herrera, MA Director, Research Support Fernande Saintilis, MBA Assistant Director, Research Support Oriali Coffigny Sr. Manager, Research Support Martha Murillo Sr. Manager, Research Support Petra Caliste Sr. Manager, Research Support

Operations Josie Lopez Assistant Director, Operations Frank Joslyn Facilities Coordinator

Clyde McCoy, Ph.D.

Student and Community

Professor, Tenured

Engagement

Orlando Garcia Sr. Desktop Support

Ginelle Bou Nassar, MPA

Veronica Bustabad Web Developer

Sr. Program Coordinator, Admissions and Recruitment Renita Revere, MBA Manager, MD/MPH Programs

Amanda Torres Writer Pilar Ramirez Sr. Administrator (Faculty Support) Jacqueline “Jackie” Lopez Executive Assistant Regla GutierrezFreeman Sr. Administrative Assistant

University of Miami Miller School of Medicine Department of Public Health Sciences

EDUCATION

• • • • • • •

ACADEMIC PROGRAMS

• • • • • • • • • •

Master of Public Health (MPH) Master of Public Health (MPH) - Generalist Master of Public Health (MPH) - Biostatistics Master of Public Health (MPH) - Epidemiology Master of Public Health (MPH) - Environmental Health Master of Public Health (MPH) - Health Services Research and Policy Master of Public Health (MPH) - Prevention Science and Community Health Master of Science in Public Health (MSPH) Master of Science in Public Health (MSPH) Generalist Master of Science in Public Health (MSPH) Epidemiology Master of Science in Public Health (MSPH) - Health Services Research and Policy Master of Science in Biostatistics (MS) Master of Science in Prevention Science and Community Health (MS) Master of Science in Climate and Health (MS Doctorate in Biostatistics (Ph.D.) Doctorate in Epidemiology (Ph.D.) Doctorate in Prevention Science and Community Health (Ph.D.)

JOINT DEGREES

• School of Medicine (MD/MPH, MD/Ph.D.) • School of Law (JD/MPH) • College of Arts and Sciences (MPA/MPH) • College of Arts and Sciences (MAIA/MPH) • College of Arts and Sciences (MALAS/MPH)

CURRENTLY DEVELOPING

• Selective Online Courses for Practitioners • Doctorate in Public Health (DrPh) Program • Online MPH Certificate • MBA/MPH Program • Executive MPH Program • Latin America MD Certificate Programin Public Health

ACCREDITATION DPHS has maintained continuous accreditation by CEPH (Council on Education for Public Health) since 1982, and are currently accredited through 2021 (we received the full 7 years at our last site visit in 2014). We will be submitting our next self-study report in 2020, with an expected site visit in Fall 2021.

University of Miami Miller School of Medicine Department of Public Health Sciences

Total Enrollment By Program FY2016 - FY2018 250

200

150

100

MD/MPH

MPH/MSPH FY16

PH.D. FY17

JOINT DEGREES

MS/BST

FY18

The Certified in Public Health (CPH) mark by the National Board of Public Health Examiners (NBPHE) is a credential that demonstrates knowledge and commitment to the field through continuing public health education. In its inaugural year, DPHS offered a pre-mock exam, a boot camp, and a post-mock exam to prepare students for the official CPH exam. For each academic year, DPHS will offer this opportunity to students enrolled in any of its graduate programs.

Source: www.nbphe.org/who-get-certified

University of Miami Miller School of Medicine Department of Public Health Sciences

RESEARCH Through innovative public health research, DPHS faculty investigates determinants of different diseases, as well as effective prevention and intervention strategies that will ultimately advance population health through training and dissemination of ground breaking discoveries. Currently, there are 39.75 full-time faculty involved in highly interdisciplinary translational research, as well as an active group of secondary and voluntary faculty from across the University, the community and beyond who are leaders in their respective fields. DPHS faculty work on research projects in countries throughout South America, the Caribbean, the Middle East, and Africa. These programs provide new understanding and effective dissemination strategies that result in important and timely impacts on the health of populations, locally, nationally and internationally. DPHS faculty are collaboratively engaged in research across the medical school and the broader University community and currently ranks #8 in National Institutes of Health (NIH) funding within UMMSM. The NIH funding rank of DPHS is favorable relative to other U.S. Public Health Schools (27th out of 65) and departments within Medical Schools (19th out of 46). In 2018, DPHS had over $11 million in NIH and other research funding across its divisions.

University of Miami Miller School of Medicine Department of Public Health Sciences

IN PUBLIC HEALTH, SOCIETY IS OUR PATIENT

Sponsored Grants Total Costs FY2016 - FY2018 12,000,000

10,000,000

10,632,817

11,088,600 10,370,755

8,000,000

6,000,000

University of Miami Miller School of Medicine Department of Public Health Sciences

FY2016

FY2017

FY2018

SERVICE STUDENTS The Public Health Student Association (PHSA) PHSA participates in Health fairs through the Department of Community Services (DOCS) program at UMMSM. Capstone Field Experience All MPH and MD/MPH students must complete a capstone field experience of at least 150 hours. We have relationships with community partners locally and abroad, and multiple students have worked with various partners. Locally • • • • • •

University of Miami partners: Pediatric Mobile Clinic, Mailman Center LEND Program IDEA Needle Exchange Miami Veterans Affairs Healthcare System Florida Department of Health CDC Miami Quarantine Station South Florida Behavioral Health Network Ear Peace: Save your Hearing Foundation Connect Familias

Internationally We provide funding for our master’s students to do public health field work abroad and in locations throughout the United States. Sixty one MPH, MD/MPH and MSPH students received a financial award to conduct their capstone field experience or capstone project over the past two academic years across 30 countries worldwide. Community Nathan McKenty, a fourth year MD/MPH student, was awarded the Florida Medical Association’s Sanford A. Mullen M.D. Award that is presented to medical students for outstanding service to the community of Florida and Florida organized medicine. Elaheh Niroomand, a fourth year MD/MPH student, was awarded the Palm Beach Medical Society Heroes in

Medicine Award from Palm Beach County Medical Societies Services. Kasha Bornstein and Austin Coyle, first year MD/ MPH students, were recipients of the Infectious Disease Society of America’s 2018 Medical Scholar of the Year award for a project titled, “A Cost Analysis of Hospitalizations for Infectious Sequela of Injection Drug Use at the County Safety-Net Hospital in Miami, Florida Following Establishment of a Syringe Exchange Program.” Latin America and Beyond Gabriela “Gaby” Pages, MPH, received the 2019 Christianson Grant to support a training opportunity with the Centers for Disease and Control (CDC) in Peru. She will be involved in their social network project with Venezuelan refugees that are living in Lima. Daniel Samano, MD, an MPH Candidate, received the Graduate Student Exemplar award from the University of Miami Graduate School. DPHS students won awards at the 2018 Eastern-Atlantic Student Research Forum (ESRF), a four-day international symposium held at UMMSM. There were 122 presentations at the conference and 24 were made by DPHS students. Students from the Learning Collaboratory in Latin America travelled to the Dominican Republic to support the CDC’s HIV seek test and treat efforts. Students partnered with PSI and assisted documenting the model of care of mobile clinics in Santiago and Puerto Plata. These mobile clinics reach out to the underserved and Haitian migrant population. Diane Zheng, a Ph.D. in epidemiology candidate, co-authored “Longitudinal Associations Between Visual Impairment and Cognitive Functioning,” a study that analyzed the health data of more than 2,500 adults, aged 65 to 84, who were followed from 1993 to 2001. The study was the first to document that vision is the dominating factor in the relationship between vision impairment and cognitive function.

“Empowering our students to transform lives and inspire them to serve our global community.” — Dean Ford University of Miami Miller School of Medicine Department of Public Health Sciences

Samuel Longworth Swift, Ph.D. in Epidemiology, was awarded an American Heart Association (AHA) Predoctoral Fellowship. This fellowship will help support Swift’s research in income volatility and its risk of causing cardiovascular disease (CVD) in individuals. Tyler Bartholomew, a Ph.D. in Prevention Science and Community Health candidate, was awarded a grant titled “Gilead FOCUS Program for HIV/HCV Testing and Linkage to Care.” Marissa Kobayashi, a Ph.D. in Prevention Science and Community Health candidate, was awarded a grant from CREATE titled “Formative Development of a Multigenerational eHealth Intervention for Grandparents and Grandchildren.” Rhoda Moise, a Ph.D. in Prevention Science and Community Health candidate, was awarded the Global Oncology Innovation Grant, funded by Sylvester Comprehensive Cancer Center. Michelle Caunca, a Ph.D in Epidemiology and Population Health Sciences candidate, received an NINDS, NIH. F-30 predoctoral grant funded for 5 years (20172022). Caunca’s mentor is Dr. Tatjana Rundek and the title of her project is “Effects of White and Gray Matter Integrity on Cognition in A Multi-Ethnic Cohort.”

FACULTY Community Dr. Eric Brown received an award from the Annie E. Casey Foundation to implement the Evidence2Success prevention system in Liberty City and surrounding communities, in partnership with the Urban Partnership of Miami Dade County Coalition. Dr. Eric Brown received two awards from the Health Foundation of South Florida to collect risk and protective factor data from youth in Liberty City, Little Havana and surrounding area schools. Dr. Eric Brown received an award from the UM Clinical and Translational Science Institute to collect risk and protective factor data in Little Havana.

University of Miami Miller School of Medicine Department of Public Health Sciences

Dr. Scott Brown is a member of the Health & Built Environment Committee, Consortium for Healthier Miami-Dade County, The Underline (a 10-mile linear trail plan underneath the Miami-Dade Metrorail), and Active Design Guidelines for Miami (invited by the Miami chapter of the American Institute of Architects). Dr. Scott Brown was interviewed in March 2019 by the American Heart Associates News for their blog post on “Living in a green, leafy neighborhood could cut heart attack risk,” as well as by Local 10 News on their segment titled “UM study finds higher levels of green space linked with lower health problems.” The Hurricane Response Hub, funded by the Centers for Disease Control and the National Network of Public Health Institutes, Florida Institute for Health Innovation (FIHI) and the UMMSM, in collaboration with the Miami Dade Department of Health, Florida International University and the Escambia Department of Health, will work to enhance disaster surveillance in addition to environmental and occupational health recovery efforts in areas impacted by Hurricanes Harvey, Irma, and Maria by building disaster-related public health workforce capacity. Dr. Mariano Kanamori’s project called PrEParados, funded by the CFAR-ADELANTE Program, studies two social networks (friendship socio-centric networks and sexual egocentric networks) of Latino men who have sex with men (LMSM) living in Miami-Dade County, Florida. The aim of this study is to understand how PrEP programs can harness the potential of social networks and venue-based affiliations to facilitate LMSM’s progress in the PrEP cascade. Dr. Roderick King’s Building a Healthy and Resilient Liberty City, a collaboration between the Florida Institute for Health Innovation (FIHI), the Miami Children’s Initiative, Catalyst Miami, the Florida Department of Health in Miami-Dade County, Jesse Trice Community Health Center and Jackson Health System, is one of 18 American neighborhood projects selected by the BUILD Health Challenge to develop innovative approaches to improve community health by addressing crime. Dr. Roderick King and FIHI are partnering with Catalyst

SERVICE CONTINUED Miami in the Kresge Foundation-funded project titled Miami Climate Resilience Collaborative to build resilience to climate change by deepening community understanding for a culture of preparedness within vulnerable communities. As part of this effort, they are also working to engage more public health and healthcare leaders in climate resilience initiatives in South Florida through building a climate and health cohort to share information, resources and to provide learning opportunities that inspire collaborative actions to protect our communities from the health impacts of climate change. Dr. Roderick King’s project, Sea Level Rise Health Impact Mapping, funded by the Kresge Foundation and partnered with Florida Atlantic University and FIHI, identify the communities in Southeast Florida that will be most vulnerable to sea level rise impacts, to identify specific potential public health risks and to correlate these risks to identified populations through regional mapping scenarios. Dr. Guillermo “Willy” Prado has an NIH funded study to evaluate the effectiveness of an online parenting intervention in preventing drug use and STI incidence in primary care settings across South Florida, as well as another study that evaluates an obesity preventive intervention in Miami-Dade County in collaboration with the Parks and Recreation System. Dr. David Lee is a Board Member and Scientific Director for Mindful Kids Miami, a community-based agency whose mission includes helping educators, healthcare providers and caregivers teach mindfulness skills to children and youth in schools and other settings. SCAN360 is an effort that involves Dr. Raymond Balise together with investigators in the University of Miami’s Sylvester Comprehensive Cancer Center to create a new mapping and visualization platform for disease surveillance of cancers in our local areas (4 county catchment area) and the state.

University of Miami Miller School of Medicine Department of Public Health Sciences

This platform is novel in that it integrates many sources of data including information on social determinants of health to better visualize and understand the burden of cancer in our communities. It was a key piece of the community engagement section of the Cancer Center Support Grant review by NCI. Dr. Daniel Feaster’s Project Aware, funded by a PCORI grant, focused on developing new statistical methods for estimating heterogeneity of treatment effects in behavioral modification strategies to reduce risky behavior for those with substance abuse. He worked closely with an advisory board consisting of members from DPHS and community representatives. Latin America and Beyond Under a collaboration between Fundacion Carlos Slim (FCS Interamerican Development Bank (IDB and Dr. Viviana Horigian, efforts are continuing to provide support to a certificate program titled AMANECE and DILAVAC. These online certificates developed by FCS and academically endorsed by DPHS, are designed to train the public health workforce of the 20% most poor regions of countries in Mesoamerica. The research agenda will allow determining the extent trainings have modified public health practice and outcomes. Supported by a UMMIA grant, Dr. Viviana Horigian and Dr. Alberto Caban-Martinez developed a collaboration with O & M medical school in the Dominican Republic. Supported by community leaders, faculty, students and community, DPHS faculty developed a roadmap for developing infrastructure at the O&M that will allow them to examine health disparities and outcomes of the population of Guachupita overtime. Faculty in DPHS continued with their existing work in Ecuador & Chile (Dr. Guillermo “Willy” Prado Colombia & Brazil (Dr. Eric Brown Mexico (Dr. Eric Brown & Dr. Viviana Horigian and Dominican Republic (Dr. Alberto Caban-Martinez. A new collaboration has been established with Instituto de Investigaciones Científicas Avanzadas y Servicios de Alta Tecnología in Panama to screen for risk and protective health factors of Panamanian youth.

Dr. Viviana Horigian delivered a one week course in Design and Implementation of Clinical Trials to researchers at the National Institute of Psychiatry in Mexico, which resulted as an expansion to her prior work and collaborations in Mexico. DPHS launched their collaboration for academic mobility with the Instituto Nacional de Salud Publica (INSP) in Mexico by facilitating student exchange during the summer. Student Gabriela Paces traveled to complete her field experience. She conducted qualitative research in cervical and breast cancer in collaboration with researchers at INSP. Supported by the AIDS Healthcare Foundation, Dr. Daniel Feaster and Dr. Viviana Horigian are leading a research project that will evaluate the impact of HIV care in migrants from Venezuela. This multi-site, multi country project, will be the first to document HIV care of the Venezuelan population in Mexico, Argentina, Colombia and the U.S., and will explore ART resistance developed in this population as a result of the interruptions in care while in Venezuela. Dr. Eric Brown received an award from the AB InBev Foundation to adapt and implement the Empresas Que se Cuidan (Businesses That Care) prevention system in Zacatecas, Mexico, which includes adaptation and implementation of the Guiding Good Choices program, the Social Development Strategy, and Brief Motivational Interviewing of youth, as part of the Global Smart Drinking Goals initiative. Dr. Taghrid Asfar’s International tobacco control project, helps Tunisia and Lebanon develop effective health warning labels for the waterpipe, and equip them with the means to implement them successfully.

Dr. Hermes Florez is a commitee member of the American Diabetes Association (ADA): • The Professional Practice Committee prepares diabetes standard of care guidelines. The guidelines were published in January of 2016 and January of 2017. • Best of ADA in India (outreach in Mumbai and Bangalore) for diabetes prevention and to address growing needs in older adults (2017). Dr. Hermes Florez is a member of the Latin American Association of Diabetes: First Consensus Report for diabetes in older adults (2016). Dr. Hermes Florez lead the Center for Disease Control and Prevention (CDC): “Prevent T2” program for diabetes prevention in high-risk populations in minority community in both English and Spanish (2016). Dr. Hermes Florez lead the Population Health in Venezuela: Prevention and Reduction of Cardio-Metabolic Risk (2017-2019) project. Dr. Mariano Kanamori has a NIDA funded study that implements innovative and advanced social network modeling to understand how Latino cultural values and acculturation stress impact social network configurations and dynamics that could then act as protective or risk factors for substance use disorders and HIV risk. Dr. Mariano Kanamori’s NIMHD funded project aims at developing scalable, network-based approaches to optimize the benefits of PrEP in Latino female migrant workers.

Dr. Hermes Florez is a Public Health Advisor for the Venezuela Humanitarian Health Crisis (2016-2019).

Dr. John Beier lead the Research and Training projects for M-D Mosquito Control supported by CDC grant: Southeast Regional Center of Excellence in Vector-Borne Disease: The Gateway Program. Dr. Beier’s joint work with M-D Mosquito Control better prepares them to maintain quality mosquito control operations throughout the county. It also improved their capacity to respond to mosquito-borne disease outbreaks (e.g., Zika, dengue, chikungunya, Yellow Fever).

Dr. Hermes Florez is part of MedGlobal – University of Miami team which addresses healthcare and nutritional needs of the migrant Venezuelan population.

Dr. John Beier’s NIH R01 “Outdoor Resting and Sugar Feeding Behaviors of African Malaria Vectors” investigates neglected aspects of two important behaviors.

Dr. WayWay Hliang is a research grant reviewer for the Italian Ministry of Health.

University of Miami Miller School of Medicine Department of Public Health Sciences

SERVICE CONTINUED Dr. John Beier and his team were able to learn about plant sources for sugar feeding, the timing of sugar-feeding, movement of sugar-fed mosquitoes from outdoors to inside houses, seasonal variation, and how vectors adapt to environmental plant sugar sources. This research facilitated the development of attractive toxic sugar baits (ATSB), which has been approved by WHO Vector Control Advisory Group (VCAG). Currently, ATSB is being tested in cluster randomized epidemiological trials in Mali, Kenya, and Zambia. Dr. John Beier is an editor for Acta Tropica, a past member of the World Health Organization Vector Control Advisory Group, past Chairman of the review committee for the Department of Defense Military Infectious Disease Research Program for Vector Biology, and past Chairman of the National Institutes of Health study panel on Vector Biology.

Dr. J. Sunil Rao will be a Distinguished Visiting Professor at the University of Cagliari (Italy) in 2019. He was chosen by a university-wide panel with the funding being provided by the Italian National Science Foundation. Dr. Daniel Feaster has many research collaborations in Vietnam and other areas of the Far East. Dr. J. Sunil Rao has visited the Karolinska Institute (Stockholm, Sweden) twice as part of an ongoing collaboration in cancer genomics.

Dr. Alberto Caban-Martinez provides scientific advisory services to various organizations in Latin America and Europe on various occupational health and safety topics. For example, first responder (EMS and firefighter) advisory in the Dominican Republic, Chile, South Korea, Ireland, and the UK. Dr. Alberto Caban-Martinez and our Medical Students in Action (MSA) team, comprised of MD-MPH, MPH and traditional MD students, visited rural villages in San Cristobal province to provide healthcare services and maintain and support community health workers. Dr. Viviana Horigian’s Corporacion Nuevos Rumbos in Colombia consists of the development of validated and data driven approaches for the identification of risk and protective factors to guide the implementation of evidence based programs for prevention of adolescent risk behaviors. Dr. Viviana Horigian’s Fundacion San Carlos de Maipo in Chile consists of the development of research capacity for Fundacion San Carlos de Maipo and implementation of a community prevention system, “Comunidades que se cuidan.”

University of Miami Miller School of Medicine Department of Public Health Sciences

PUBLIC HEALTH

WE ARE...WORLDWIDE

University of Miami Miller School of Medicine Department of Public Health Sciences

DPHS FACULTY DPHS is an academic center of excellence that strives to improve the health of the public â&#x20AC;&#x201C; one community at a time â&#x20AC;&#x201C; through research, education, and service. We promote an environment of learning and inquiry, stressing the scientific method as a way of building knowledge about common pathways that affect health. DPHS faculty ask provocative questions that challenge the status quo, build new models to test, and encourage students to conceive innovative ways to advance the field and bring effective solutions to communities that need them. Our highly qualified, experienced and diverse faculty maintain an intimate, hands-on and personal approach. In addition, we combine research and training with service and interventions to translate our discoveries into policy and practice.

University of Miami Miller School of Medicine Department of Public Health Sciences

FACULTY BIOGRAPHIES Taghrid Asfar, MD, MSPH, is a Research Assistant Professor of Epidemiology in DPHS at UMMSM, and a Member at the Sylvester Comprehensive Cancer Center. She is also a member of the founding team of the Syrian Center for Tobacco Studies, a pioneerresearch capacity-building institution in the Middle East. She has extensive experience in tobacco control research nationally and internationally, including epidemiological studies of tobacco use, randomized clinical trials of behavioral smoking cessation interventions, and tobacco policies and regulations. She has published numerous scientific reports in prestigious journals (e.g. Cochrane review, Tobacco Control, and Addiction). Currently, as part of her efforts on her NCI R21 grant, Dr. Asfar is testing a novel worksite smoking cessation intervention for Hispanic construction workers in South Florida. She also serves as a Co-Investigator on a smoking cessation project funded by the Florida Department of Health/ James and Esther King which aims at addressing racial/ethnic tobacco health disparities via group interventions. Dr. Asfar has been recently awarded an NIH R01 grant entitled “Translating Evidence and Building Capacity to Support Waterpipe Control in the Eastern Mediterranean.” This project aims to develop and test the effectiveness of waterpipespecific health warning labels targeting young adults in the Middle East (Tunisia and Lebanon). Raymond Balise, Ph.D., is a Research Assistant Professor in DPHS and the Department of Urology at UMMSM and is affiliated with the Sylvester Comprehensive Cancer Center. Previously, he was a Senior Lecturer, Staff Biostatistician and Biostatistics Program Coordinator and University of Miami Miller School of Medicine %FQBSUNFOU PG 1VCMJD )FBMUI 4DJFODFT

Project Director for the Statistical Programming Group Spectrum at the Stanford University School of Medicine. In that role, he helped design and implement hundreds of biomedical research projects. Dr. Balise currently supports all research for the University of Miami Department of Urology, including projects assessing the diagnosis, treatment and survival of people impacted by urological malignancies. His current research interests focus on health-related quality of life in men with prostate cancer. He is working with researchers in Spain and Colombia to validate a Spanish version of a widely used health-related quality of life instrument (EPIC-26,) which is used to assess men diagnosed with prostate cancer. Dr. Balise currently teaches Statistical Programming and Medical Biostatistics in the Masters and Ph.D. Programs in DPHS. In external activities, he is the cochair of the International REDCap REDLOC committee and the REDCap REDLOC Spanish Subcommittee. John C. Beier, Sc.D., is a Professor and Director of the Division of Environment and Public Health in DPHS at UMMSM. Dr. Beier’s research career is committed to the ecology and control of vector-borne diseases, including malaria, dengue, Zika, other arboviruses, and leishmaniasis. With a strong network of international collaborators and University of Miami faculty and students from several departments and centers, interdisciplinary research is being conducted on vector species of mosquitoes and sand flies, pathogen transmission dynamics, determinants of human risk, novel vector control methods, and innovative integrated vector management strategies for disease control. He has 300 publications. Dr. Beier’s current research is supported by two NIH grants that involve studies on malaria epidemiology and control in Latin America, and the ecology and behavior of African malaria vectors, and a CDC grant for vector-borne diseases in southeastern U.S. He is also involved with research on new approaches for malaria and 21

FACULTY BIOGRAPHIES CONTINUED dengue vector control. He was ranked by BiomedExperts #1 for Anopheles mosquitoes and #2 for Disease Vectors. Dr. Beier teaches Ecology and Control of Vector-Borne Diseases, and in 2013 won the Best Teacher award. In external activities, he is an Editor for Acta Tropica, a past member of the World Health Organization Vector Control Advisory Group, past Chairman of review committee for the Department of Defense Military Infectious Disease Research program for Vector Biology, and past Chairman of the National Institutes of Health study panel on Vector Biology. Scott C. Brown, Ph.D., is an Associate Research Professor in DPHS at UMMSM. He has a secondary appointment in the University of Miami School of Architecture. Previously, he completed postdoctoral fellowships in cognitive aging and behavioral health at the University of Michigan’s Institute for Social Research and Division of Rheumatology. Dr. Brown teaches the EPH 640 (Urban Environment & Public Health) course, which he developed. His main area of research is on neighborhood built (physical) and social environments and public health. Dr. Brown is currently the UM Site PI of a CDC-funded project on promoting physical activity opportunities through Miami-Dade Parks, funded by the CDC’s Partnerships to Improve Community Health (PICH), in partnership with the Florida Department of Health at Miami-Dade, and Miami-Dade Parks, Recreation and Open Spaces (MDPROS). He is also an investigator on another CDC-funded project led by University of Florida researchers examining built and social environmental risk and protective factors for Zika and other mosquito-borne illnesses. Dr. Brown was recently Principal Investigator (with Professor Elizabeth Plater-Zyberk, in the School of Architecture) of a HUD-funded research study examining the relationship of built-environment “walkability” characteristics (e.g., land-use mix; parks; greenery; transit) to health-outcomes and

University of Miami Miller School of Medicine Department of Public Health Sciences

health-care costs among Medicare/Medicaid beneficiaries in Miami-Dade County, Florida. He was also recently an Investigator on an NIH-funded study examining the relationship of built environment walkability to Hispanic immigrants’ physical activity and progression on metabolic syndrome indicators. He was previously Co-PI on an NIHfunded study examining the relationship of the built environment to Hispanic elders’ social behaviors and their cognitive, affective, and physical functioning. Other research examines the relationship of the health-care built–environment to patients’ health outcomes; the role of the built environment in children’s conduct problems; and the role of accreditation of echocardiographic testing facilities utilized by Medicare beneficiaries nationally. In summary, Dr. Brown has a general interest in the impacts of neighborhood physical and social environments on residents’ health and well-being across their life span. Eric C. Brown, Ph.D., is an Associate Professor at UMMSM’s DPHS’ Division of Prevention Science and Community Health where he directs the Implementation Science track for DPHS’s Ph.D. Program. Dr. Brown works on the development, implementation, and testing of community- and schoolbased preventive interventions in the United States and in Latin America. He is the Principal Investigator of a U.S. National Institute on Drug Abuse-funded study examining risk factors for adolescent drug use among the United States, Colombia, Chile, and Brazil; and is a former Investigator on the Community Youth Development Study’s community-randomized controlled trial of the Communities That Care (CTC) prevention system. Dr. Brown also is a former Co-Principal Investigator on the adaption and implementation of the CTC prevention system in Chile (called Comunidades Que Se Cuidan, in Spanish), and has consulted on the adaptation and implementation of Comunidades Que Se

Cuidan in Colombia. Prior to coming to the UM, Dr. Brown was a faculty member with the Social Development Research Group (SDRG) at the University of Washington’s School of Social Work. At the SDRG, Dr. Brown was the Principal Investigator of a school-randomized controlled trial of Steps to Respect: A Bullying Prevention Program and a Co-Investigator of the Bill and Melinda Gates Foundation-funded Supporting Early Adult Transition Study, a developmental evaluation of the Jim Casey Youth Opportunities Initiative. Other research projects that Dr. Brown worked on include the Multisite Evaluation of Second Step: Student Success through Prevention of Bullying and Sexual Harassment, the International Youth Development Study, Preventing Adolescent Cannabis Use in the Netherlands and the United States--A Bi-national Investigation of the Communities That Care Prevention System, the Raising Healthy Children Project, and the National Adolescent Treatment Study. Dr. Brown’s research interests center around the application of advanced research methods to evaluate the effectiveness of prevention programs and implementation systems. He currently teaches Implementation Science, Disease Prevention and Health Promotion, and Advanced Quantitative Research Methods in Prevention Science. He is a member of the Society for Prevention Research International Committee and was the recipient of the 2013 International Collaboration Alberto Caban-Martinez, Ph.D., DO, MPH, is a board certified osteopathic physician and epidemiologist, and an Assistant Professor at DPHS in the Division of Environment and Public Health at UMMSM. He is the Director of the Musculoskeletal Disorders and Occupational Health Lab and Associate Director of the Miami Occupational Research Group (MORG). His primary program of research concerns the prevention of musculoskeletal disorders among U.S. workers. He is the principal investigator of the NIOSH-funded Musculoskeletal Study of Construction workers’ Longitudinal Exposures (MUSCLE) which follows a cohort of 500 commercial

University of Miami Miller School of Medicine Department of Public Health Sciences

construction workers using a longitudinal study design with repeated measurements to better understand the occurrence and course of multisite musculoskeletal acute and chronic pain and its severity, as well as its association to occupational and non-occupational risk factors. He is also co-leading the Home Health Occupations - Musculoskeletal Examinations (HHOME), a mixed-methods pilot research study examining the musculoskeletal disorders in minority home health workers (i.e., home health aides, personal care attendants, home makers, etc.) with the primary goal of understanding occupational factors that can reduce overexertion and physical demands in their work environment. He most recently completed data collection of a NIAMS-funded mixed-methods study to develop and validate an ergonomics and fatigue survey instrument for commercial construction workers. He is a standing member of the NIOSH National Occupational Research Agenda (NORA) Construction Sector and Mining Sector Council as well as a member of the National Board of Public Health Examiners, Item Writing Committee. Adam Carrico, Ph.D., is an Associate Professor in DPHS and Psychology at the University of Miami. His research program focuses broadly on developing and testing behavioral interventions that address the biopsychosocial vulnerabilities to optimizing HIV/ AIDS prevention, addressing substance use and misuse, and supporting cancer prevention in marginalized, underserved populations. A strong focus of Dr. Carrico’s clinical research to date has been to examine integrative approaches to boost the effectiveness of contingency management for HIV/ AIDS prevention with individuals who use stimulants such as methamphetamine. At the University of Miami, Dr. Carrico is pursuing research to test a trauma-informed intervention to boost the effectiveness of contingency management with HIV-positive, cocaine-using women as well as clinical research to examine the biobehavioral pathways whereby substance use may contribute to inflammation and immune activation

FACULTY BIOGRAPHIES CONTINUED in HIV. In his prior work at the University of California, San Francisco (UCSF), Dr. Carrico led a series of studies demonstrating that HIV-positive stimulant users experience profound health disparities and he documented the outcomes of novel approaches to cognitive-behavioral substance abuse treatment for HIV/AIDS prevention. Dr. Carrico’s clinical research program provides an ideal platform to mentor the next generation of prevention researchers. At UCSF, he successfully mentored two predoctoral students, two postdoctoral fellows, and one junior faculty member to obtain NIH funding for their research (i.e., F31, R36, R03, and K23). Dr. Carrico’s extensive contributions to research, mentoring, and service were recognized in 2015 by the American Psychological Association with a Psychology and AIDS Emerging Leader Award. Dr. Carrico is an Honorary Professor of Psychiatry at the University of Cape Town (2019-Present) as well as an incoming standing member for the HIV Comorbidities and Clinical Studies (HCCS) NIH study section.

subtypes and corresponding gene signatures. He is the developer of the web-based software “TNBCtype”, which has been widely used by the breast cancer research community. Daniel Andrés Díaz-Pachón, Ph.D., is a Research Assistant in the Division Professor of Biostatistics in DPHS at UMMSM. His research, current and former, can be divided in four areas: In probability, he is working population genetics. on Particularly, his current interest is on the Spatial LambdaFleming-Viot process (SLFV) to model evolution in the spatial continuum, developed by Alison Etheridge and collaborators. Surprisingly enough, his current work relies

heavily

the

research

for

his

doctoral

dissertation, which was entirely focused on continuum percolation and large deviations of stable allocations.

Xi (Steven) Chen, Ph.D., is an Associate Professor of Biostatistics in DPHS at UMMSM. He is also the Director of the Biostatistics and Bioinformatics Shared Resource at the Sylvester Comprehensive Cancer Center. Previously, he was a tenured Associate Professor at Vanderbilt University School of Medicine. Dr. Chen’s research interests focus on statistical genomics for cancer research, especially developing and applying innovative statistical and bioinformatics methodology to facilitate translational genomic research from bench to clinic. Dr. Chen is the Principle Investigator of a NCI R01 grant “Integrative prediction models for metastasis risk in colon cancer” which collects data on mRNA expression, somatic mutations, and clinical information to develop clinical-genomic risk prediction models and to identify subtypes for colon cancer patients. Dr. Chen is also a major contributor for identifying six triple-negative breast cancer (TNBC)

University of Miami Miller School of Medicine Department of Public Health Sciences

information

theory,

working

active

information, based on Bernoulli’s Principle of Insufficient Reason. In this endeavor, he is collaborating with engineer Robert Marks II, who developed the concept with his collaborators for uniform distributions. Dr. DíazPachón’s project is on the generalization of the concept

general

distributions.

machinelearning, he has currently begun to work with Dr. Sunil Rao and Dr. Hemant Ishwaran on the problem of learnability, which depends on a concept called stability. Part of the interest is to analyze, and hopefully improve, existing inequalities. In the past, as part of his postdoctoral research and together with Dr. Sunil Rao and Dr. Jean-Eudes Dazard, he was able to transform a supervised bump-hunting algorithm into a more efficient unsupervised one, when the sample is large. In theoretical statistics, together with Dr.’s Sunil Rao and Jean-Eudes Dazard, he is working to understand when in learning settings, mainly regression, the rotation (not the projection of the space) to principal components of the explanatory variables makes sense to explain

the response. In order to achieve this goal, Dr. Díaz-Pachón has relied entirely on stochastic geometry, partially solving this open problem of around 70 years. He and his collaborators continue working on a full solution to this problem. Tali Elfassy, Ph.D., MSPH, is an Assistant Research Professor of Epidemiology in DPHS at UMMSM. Dr. Elfassy’s research focuses on the area of cardiovascular disease and minority health. Her program of research focuses on understanding how complex cardiovascular disease risk shape health disparities among factors minority populations and ultimately inform prevention strategies. Dr. Elfassy received her MSPH from the George Washington University Milken Institute School of Public Health, after which she worked as a Research Associate for Pfizer and then as a Research Scientist for the New York City Department of Health and Mental Hygiene. Dr. Elfassy completed her Ph.D. in Epidemiology at the University of Miami where she also conducted her American Heart Association funded post-doctoral fellowship. Her current research is focused on cardiovascular disease and risk factors for cardiovascular disease, specifically sodium and potassium consumption among U.S. Hispanics/Latinos. She is currently a CTSI KL2 Scholar. In her research, Dr. Elfassy works with several epidemiologic cohorts including, the Hispanic Community Health Study/Study of Latinos (HCHS/ /SOL), the Reasons for Geographic and Racial Differences in Stroke (REGARDS), and the Coronary Artery Risk Development in Young Adults (CARDIA). Daniel J. Feaster, Ph.D., is a Professor in the Biostatistics Division of DPHS at UMMSM. He has over 25 years of experience in design, implementation and analysis of large longitudinal studies, including clinical trials of HIVUniversity of Miami Miller School of Medicine Department of Public Health Sciences

positive and drug abusing populations as well as both individualand family-focused preventive and treatment interventions. He has been the statistician on numerous federally funded projects, including center grants, RO1s, cooperative agreements and multi-site trials. Dr. Feaster has expertise in multi-level (also known as hierarchical linear) modeling, structural equation modeling and extensive experience with longitudinal analysis and methods for handling missing data. Hermes Florez, MD, MPH, Ph.D., is a Tenured Professor in the Departments Public Health Sciences and Medicine at the University of Miami (UM) Miller School of Medicine and Director of the Geriatric Research, Education, and Clinical Center (GRECC) at the Miami Veterans Affairs Healthcare System. (VA) Dr. Florez received his medical degree with honors (Summa Cum Laude) from the University of Zulia-School of Medicine in Maracaibo, Venezuela. He completed postgraduate training in Internal Endocrinology, & Geriatrics, and Medicine, graduate studies in Epidemiology (PhD) and Public Health (MPH) at UM/ Jackson Memorial Medical Center. In 1996 he joined the Diabetes Prevention Program Research Group at the UM and he is Co-Leading the Aging Working Group in this National Institutes of Health (NIH)-funded multicenter clinical trial. In addition, Dr. Florez is the Miami Principal Investigator of the VA-funded Million Veteran Program, the largest genomics initiative in the U.S. and Miami Principal Investigator of the NIH-funded GRADE, a comparative effectiveness research study in patients with type 2 diabetes. Dr. Florez has a research interest on the prevention and management of cardiovascular disease and diabetes and has been actively involved in the evaluation of patients at high-risk for diabetes and other age-related diseases in studies funded by the Pan American Health Organization, the American Heart Association, and the International Diabetes Federation – Bringing Research in Diabetes to Global Environments and Systems. In June of 2012, Dr. Florez was appointed Director of 25

FACULTY BIOGRAPHIES CONTINUED the Division of Epidemiology and Population Health supporting the training of future healthcare leaders through the MPH, MD/MPH and the Epidemiology PhD programs at UM. He also served as National CoChair of the GRECC Directors Network (2015-2017) with the purpose of coordinating initiatives among these 20 Geriatric Centers of Excellence to promote healthier aging in the US population, in alignment with initiatives promoted by the World Health Organization/Pan American Health Organization. Julio Frenk, MD, Ph.D., MPH, a noted leader in global health and a renowned scholar became the sixth President and a Professor in DPHS at UM on August 16, 2015. Prior to joining the University of Miami, Dr. Frenk was Dean of the Faculty at the Harvard T.H. Chan School of Public Health since January 2009. While at Harvard, he was also the T & G Angelopoulos Professor of Public Health and International Development, a joint appointment with the Harvard Kennedy School of Government. Dr. Frenk served as the Minister of Health of Mexico from 2000 to 2006. There he pursued an ambitious agenda to reform the nation’s health system and introduced a program of comprehensive universal coverage, known as Seguro Popular, which expanded access to health care for more than 55 million previously uninsured Mexicans. Dr. Frenk was also the founding directorgeneral of the National Institute of Public Health in Mexico, one of the leading institutions of its kind in the developing world. In 1998, he joined the World Health Organization (WHO) as executive director in charge of Evidence and Information for Policy, WHO’s first-ever unit explicitly charged with developing a scientific foundation for health policy to achieve better outcomes. Other professional accomplishments include serving as a senior fellow in the global health program of the Bill & Melinda Gates Foundation, as president of the Carso Health Institute in Mexico City, founding chair of the board University of Miami Miller School of Medicine Department of Public Health Sciences

of the Institute for Health Metrics and Evaluation at the University of Washington, and co-chair of the Commission on the Education of Health Professionals for the 21st Century, which published its influential report in the leading journal The Lancet in 2010, triggering a large number of follow-up initiatives throughout the world. Dr. Frenk holds a medical degree from the National University of Mexico, as well as a master of public health and a joint Ph.D. in Medical Care Organization and in Sociology from the University of Michigan. He has been awarded honorary doctorates from several institutions of higher learning. In September of 2008, Dr. Frenk received the Clinton Global Citizen Award for changing “the way practitioners and policy makers across the world think about health.” In 2016, he received the Welch-Rose Award for Distinguished Service to Academic Public Health from the Association of Schools and Programs in Public Health. Dr. Frenk is a member of the U.S. National Academy of Medicine, the American Academy of Arts and Sciences, and the National Academy of Medicine of Mexico, and is on the board of the United Nations Foundation. foundation for health policy to achieve better outcomes. Other professional accomplishments include serving as a senior fellow in the global health program of the Bill & Melinda Gates Foundation, as president of the Carso Health Institute in Mexico City, founding chair of the board of the Institute for Health Metrics and Evaluation at the University of Washington, and co-chair of the Commission on the Education of Health Professionals for the 21st Century, which published its influential report in the leading journal The Lancet in 2010, triggering a large number of follow-up initiatives throughout the world. Dr. Frenk holds a medical degree from the National University of Mexico, as well as a master of public health and a joint Ph.D. in Medical Care Organization and in Sociology from the University of Michigan. He has been awarded honorary doctorates from several institutions of higher learning. In September of 2008, Dr. Frenk received the Clinton Global Citizen Award for changing “the way practitioners and policy makers

across the world think about health.” In 2016, he received the Welch-Rose Award for Distinguished Service to Academic Public Health from the Association of Schools and Programs in Public Health. Dr. Frenk is a member of the U.S. National Academy of Medicine, the American Academy of Arts and Sciences, and the National Academy of Medicine of Mexico, and is on the board of the United Nations Foundation. Adriane Gelpi, Ph.D., is an Assistant Professor in DPHS and Director of Health Policy at the Institute for Bioethics and Health Policy at UMMSM. She holds a Ph.D. in Health Policy and Ethics from Harvard University, an MPH in History and Ethics of Public Health and Medicine from Columbia University’s Mailman School of Public Health, and an AB, magna cum laude, from Harvard University in History and Science, where she received both the Rothschild and Hoopes Prizes. Prior to joining UM, she held the honor of serving as the inaugural Harvard fellow at the Tel Aviv University’s Center for Ethics, followed by an NIHfunded postdoctoral fellowship as Social Medicine at the University of North Carolina Chapel Hill. Her scholarship and teaching examine issues of ethics in global health policy and governance, with a focus on how public engagement and democratic deliberation may influence priority setting for health resource allocation. Her research has been published in leading journals such as the Lancet and Health Affairs. Her work has been funded by national and international agencies and foundations, including the National Institutes of Mental Health’s Office of AIDS Research, the World Health Organization, Pan American Health Organization, David Rockefeller Center for Latin American Studies at Harvard University, the Brocher Foundation in Geneva, Switzerland, the CARSO Institute in Mexico City, and the United National Millennium Development Goals Centre in Nairobi, Kenya. Since 2016, she has led several projects related to the public health response to Zika, including serving as Co-Pi of the Zika Policy

University of Miami Miller School of Medicine Department of Public Health Sciences

in the Americas Project, funded by the AIDS Healthcare Foundation. Dr. Gelpi adds to the Division expertise in health policy, and contributes new areas of focus in global health policy and ethics. She organized and hosted a large and successful academic and community forum on “Where do we go next on Zika? An Interactive Session on Public Deliberation and Training Ethics for Better Policy Making.” Dr. Gelpi also developed a new graduate course for the DPHS MPH program on Global Health and Global Justice. Audrey Harkness, Ph.D., is a clinical psychologist and a Research Assistant Professor of Prevention in DPHS at the UMMSM. Dr. Harkness’ work focuses on optimizing mental and physical health for sexual and gender minority (SGM) communities with a focus on HIV-prevention. Prior to her graduate training, Dr. Harkness worked in HIV-prevention and SGM health at the University of California, San Francisco AIDS Health Project and the San Francisco Department of Public Health AIDS Office. Dr. Harkness completed her Ph.D. in Counseling, Clinical, and School Psychology at the University of California, Santa Barbara, where her work focused on understanding and improving SGM mental health. She is now a postdoctoral fellow in the HPAC Lab at UM, where she is a collaborator, coordinator, clinical supervisor, and interventionist on several funded studies focused on HIV-prevention and care. Her current work focuses on HIV-related syndemics, resilience, and PrEP among sexual minority men. Dr. Harkness is also starting a new study that will identify barriers and facilitators to Latino men who have sex with men’s engagement in HIV-prevention and behavioral health services. In her future work, Dr. Harness plans to conduct community-based research with implications for interventions to reduce SGM health disparities.

FACULTY BIOGRAPHIES CONTINUED WayWay Hlaing, Ph.D., is an Epidemiologist and an Associate Professor of professional practice (Educator) in DPHS at UMMSM. She is also the Director of the Ph.D. in Epidemiology program in DPHS. Previously, she held a tenured faculty position in the Department of Epidemiology and Biostatistics at Stempel School of Public Health at Florida International University of Miami. She practiced as a physician before pursuing her graduate degrees in Health Sciences and Epidemiology. Dr. Hlaing’s teaching career began during her graduate studies in early 1990s. She was a recipient of two prestigious awards at FIU: Faculty Senate’s Excellence in Graduate Teaching Award and Stempel Public Health Association (SPHA)’s Faculty Advisor Award. She currently teaches core and elective epidemiology courses in the Master’s, Ph.D., and MD/MPH programs in DPHS at UM: Fundamentals of Epidemiology, Advanced Epidemiologic Methods I and II, Ethics in Epidemiology, and Chronic Disease Epidemiology. Dr. Hlaing’s current research interests focus on the areas of obesity and cardiovascular disease epidemiology. Other research involves weight status and extreme weight loss practice among Florida youth. She serves on several DPHS committees: Admission, Curriculum, and Graduate Executive Program Committees. In external activities, she serves on the Ethics Committee of the American College of Epidemiology (ACE), and the Educational Committee of the Society for Epidemiologic Research (SER). Viviana E. Horigian, MD, MHA, is an Associate Professor in DPHS at UMMSM. She is currently serving as the Director of Public Health Education and the Director of the Americas Initiative for Public Health Innovation. She is also the Executive Director of the Florida

University of Miami Miller School of Medicine Department of Public Health Sciences

Node Alliance of the National Drug Abuse Treatment Clinical Trials Network (CTN) housed at the University of Miami. The Florida Node Alliance is a partnership between scientists and program leaders at the University of Miami and with scientist and practice leaders from community treatment agencies located in Florida, Colorado, North Carolina, Georgia, Massachusetts, Puerto Rico, and the Virgin Islands. Partner scientists and practitioners design, implement and train in interventions for alcohol and drug abuse treatment. Dr. Horigian has contributed to the design and implementation of the trials led by the Florida Node Alliance and manages its day to day operations. She has more than 15 years of experience in the implementation of multi -site randomized clinical trials. Most of her research within the CTN network has been dedicated to evaluate the effects o f a family therapy intervention called Brief Strategic Family Therapy (BSFT®) for adolescent drug abuse. Dr. Horigian’s research career has been committed to improving practice through the implementation of clinical trials in real-world settings, and more recently in creating the local capacities that would allow the implementation of such trials. She was the Principal Investigator of a technology transfer project that aimed to develop the research infrastructure for the implementation of rigorous randomized clinical trials in Mexico. In this role, she mentored investigators from the National Institute of Psychiatry in Mexico on the design, implementation, safety and interpretation of results of RCTs in real-world treatment settings. Due to her work, she received a recognition from the National Institutes of Psychiatry in Mexico for hers and the Florida Node Alliance contributions on the establishment of a Mexican Clinical Trials Network. She has used the same methodology for technology transfer to develop research capacity in Ecuador and Chile. Due to her international leadership, she was honored with the 2015 National Institute on Drug Abuse (NIDA) International Program Award of Excellence. She is a member of the Society of Clinical Trials and the National Hispanic Science Network.

Jennifer Hu, Ph.D., is a Professor in DPHS, Biochemistry and Molecular Biology, and Human Genetics and Genomics at the UM. As a trans-disciplinary cancer researcher, she has training in basic sciences (Ph.D. in Biochemistry and Molecular Biology) and cancer (M.S. in Biostatistics and Epidemiology) and her research mainly focuses on the molecular and genetic mechanisms of breast cancer risk and survival disparities and implication of DNA damage and repair in precision medicine. The pioneer research from her laboratory and collaborative effort that has significant impact on cancer research field include: (1) deficient DNA repair and elevated DNA damage in human breast and prostate cancer risk; (2) racial/ethnic-specific polygenic models of DNA repair in human cancer risk and tumor TP53 mutations; (3) functional implication of DNA repair genotypes in human cancer risk and targeted therapies; (4) gene-diet interactions in human colon and breast cancer risk; and (5) genome-wide association studies of novel breast cancer and ER-negative breast cancer susceptibility loci in women of African ancestry. She is the course director for Molecular and Genetic Epidemiology and Cancer Epidemiology and Prevention. Her research program has been continuously funded for more than 20 years with peer-reviewed grants from NIH/NCI/ACS/DOD/FL since 1992. Her broad scientific expertise includes basic laboratory research in DNA damage/repair, molecular and genetic epidemiology, genomic prediction models of survival, precision medicine, and cancer health disparities. With her diverse research background and a strong commitment to training/education, she has successfully mentored a number of young scientists with outstanding career development. She has served on more than 50 NIH/NCI/DOD study sections; became a regular member of the NCI subcommittee F for training grants in 2013 and the chair of the DOD prostate cancer research study section since 2011. Dr. Jennifer Hu has served in several NIH study sections and the Congressional Directed Medical Research Program (CDMRP)University of Miami Miller School of Medicine Department of Public Health Sciences

breast

cancer

and

prostate

cancer

programs.

Hemant Ishwaran, Ph.D., is a Professor in DPHS and is the Director of Statistical Methodology and the Director of Graduate Studies in the Division of Biostatistics at UMMSM. Dr. Ishwaran is also affiliated with the Sylvester Comprehensive Cancer Center (SCCC) and the Center for Computational Sciences (CCS). Dr. Ishwaran’s research involves machine learning methods and he has pioneered open source software for random forests, an ensemble treebased technology. Dr. Ishwaran has worked with the American Joint Committee on Cancer (AJCC) using random forests to develop a data driven stage grouping for esophageal cancer patients for the 7th edition of the AJCC Cancer Staging Manual. Dr. Ishwaran is the Joint-Editor for the Sankhya A and B series journal. Mariano Kanamori, Ph.D., is an epidemiologist committed to reducing health disparities in underserved communities. He has over twenty-six years of experience applying qualitative and quantitative methodologies to global health issues. Dr. Kanamori’s community based participatory research (CBPR) studies using advanced social network analysis have focused on substance use disorders and HIV among underserved communities in Latin America, sub-Saharan Africa and the U.S. Dr. Kanamori’s research and initiatives have operated under the auspices of of The National Institutes of Health, USAID-PEPFAR, The European Union, UNICEF, Peru Health Ministry, Family Planning Management/ John Snow, The Population Council, Salesian Missions-Ethiopia, Maryland Department of Health, and Asociación Benéfica Prisma Dr. Kanamori has published 24 scientific papers in peer-reviewed journals and co-authored a chapter in Health Issues in Latino Males: A Social and Structural Approach (2008, Rutgers University Press), which focused on Latino males’ health status in the 29

FACULTY BIOGRAPHIES CONTINUED U.S. He has presented his work in 48 national and international conferences and talks. Dr. Kanamori is an Assistant Professor at UMMSM Division of Prevention Science and Community Health. At UM, he also leads the PROGRESO (Programa de Redes Sociales) Lab where he is implementing two NIH funded projects. The first study (R00), funded by NIDA, implements innovative and advanced social network modeling using dyadic, egocentric, two-mode network, spatial, and multilevel mediation analyses to understand how Latino cultural values and acculturation stress impact social network configurations and dynamics that could then act as protective or risk factors for substance use disorders and HIV risk in the Latino seasonal farmworker community. The second study called PrEParados, funded by the CFAR-ADELANTE Program, studies two social networks (friendship socio-centric networks and sexual egocentric networks) of Latino men who have sex with men (LMSM) living in Miami-Dade County, Florida. The aim of this study is to understand how PrEP programs can harness the potential of social networks and venue-based affiliations to facilitate LMSM’s progress in the PrEP cascade. Dr. Kanamori teaches the course EPH 647 CBPR - Community Based Participatory Research. This course is designed to provide students with a robust and comprehensive theoretical and practical foundation in CBPR. While the majority of this course focuses on traditional CBPR methodology for geographically bound communities, theoretical lectures have been designed to be cutting edge by including virtual communities. Dr. Kanamori has advanced HIV and substance use disorder implementation in the first social network study which analyzes how the opioid epidemic is evolving in the Latino community. The second phase of this study is one of three proposals: The University of Miami has selected for submission to NIH for the “Ending the HIV Epidemic: A Plan for America” initiative.

University of Miami Miller School of Medicine Department of Public Health Sciences

Roderick K. King, MD, MPH, is currently Assistant Dean of Public Health Education and MD/MPH Program Director, Associate Professor in DPHS at UMMSM, Associate Professor in the Department of Pediatrics and Chief Executive Officer (CEO) for the Florida Institute for Health Innovation. He also holds a faculty appointment at the Massachusetts General Hospital (MGH) Disparities Solutions Center, Mongan Institute for Health Policy. Prior to coming to the University of Miami, Dr King held at the Harvard T.H. Chan appointments School of Public Health and Harvard Medical School where he was formerly Director of the Program on Cultural Competence in Research in Harvard Clinical Translational Science Center Catalyst). His academic work/ (Harvard teaching and key consulting roles focus on minority health policy and improving the health of underserved communities and organizational change via leadership to address health disparities. Prior to his current work, Dr. King was the New England Regional Director for the Health Resources and Services (HRSA), U.S. Department of Administration Health and Human Services, and a Commander in the U.S. Public Health Service where he was responsible for the overall management of $190M in programs and grants, regional staff and activities in primary care, agency maternal and child health, HIV/AIDS, and the National Health Service Corps. Dr. King served from 2006-2009 as one of two Inaugural Institute of Medicine (IOM) Fellows in the National Anniversary Academy of Sciences where he served on the Board on Global Health and on the study committee, "The US Commitment to Global Health." In 2011, Dr. King was selected as one of twenty scholars in the Western Hemisphere for the new Fulbright Regional Network for Applied Research (NEXUS) Program to engage in 30

collaborative thinking, analysis, and problem-solving Director of the Harvard Global Equity Initiative and to improve the quality of life for communities in Associate Professor at the Harvard Medical School. the region. She has held senior government posts in Mexico and Colombia and worked for bilateral and multilateral From 2010 to 2011, Dr. King served as the Senior agencies including the World Health Organization, Advisor to the Bureau of Primary Health Care, the World Bank, and UNICEF. She maintains a Health Resources and Services Administration, research base in Mexico anchored at the Mexican U.S. Department of Health and Human Services Health Foundation and the National Institute of and served as Chairman of the U.S. Department Public Health of Mexico. She has produced over of Health and Human Services Advisory Committee 170 academic and policy publications, including on Minority Health from 2012 to 2016. Dr. King is several papers on Mexico and health reform in The Board Certified in Pediatrics and a Fellow in the Lancet where she also recently co-authored the American Academy of Pediatrics. Dr. King also served Commission Report on Women and Health. She is as the Region One HRSA Director under the Clinton currently Chair of the Lancet Commission on Global and GW Bush presidential administrations. Dr. King Access to Palliative Care and Pain Control. Dr. Knaul has led several innovative educational initiatives, works as both a researcher and advocate such as the first CITI Human Subjects training in on cancer globally. After she was Cultural Competence in Research, new courses, diagnosed with breast cancer in 2007, programs, and certificates, like Public Health and Dr. Knaul founded the Mexican non-profit Social Entrepreneurship and Violence as a Public organization, Cáncer de Mama: Tómatelo a Health Issue. Pecho, which undertakes and promotes research, advocacy, awareness, and early detection initiatives An internationally renowned for breast cancer throughout Latin America. health economist and Her journey is documented in her book Beauty expert in Latin American without the Breast, and has been featured in The health systems and social Lancet, Science and Cancer Today. Her program sectors, Felicia Knaul, of research on breast cancer and health systems. Ph.D., is a Professor in Min Lu, Ph.D., is a Research DPHS at UMMSM and has Assistant Professor of secondary appointments Biostatistics in DPHS at UMMSM. in the Department of She received her Doctoral International Studies and the degree in Biostatistics from Department of Anthropology the University of Miami in 2018. in the College of Arts & Sciences, the Department Her current work is centered of Health Sector Management and Policy in around developing and the School of Business Administration, and the integrating machine learning Division of Population Health and Computational approaches to detect the Medicine in the Department of Medicine. Dr. Knaul’s causal relationship between research focuses on global health, cancer and breast cancer in low- and middle-income countries, treatments and outcome and facilitate personalized women and health, health systems and reform, treatment decision. She has developed several health financing, access to pain control and statistical models with her advisor, Dr. Hemant palliative care, poverty and inequity, gender Ishwaran, for estimating individual treatment effects equity and female labor force participation, and and obtaining individualized treatment rules that children in especially difficult circumstances. can accommodate continuous, binary, or survival Prior to coming to Miami, Dr. Knaul served as outcomes. She also works on statistical inferences of

University of Miami Miller School of Medicine Department of Public Health Sciences

FACULTY BIOGRAPHIES CONTINUED Random Forest Variable Importance, which permit clinicians to connect informative features to patient outcomes and treatment effects. For example, she applied her methodological framework to ischemic cardiomyopathy and esophageal cancer with Dr. Ishwaran and surgeons from the Cleveland Clinic, with the purpose of facilitating precision therapy using observational dataset that identifies the specific treatment predicted to maximize survival for a patient. Paulo S. Pinheiro, Ph.D., is a Research Associate Professor of Epidemiology in DPHS at UMMSM, with over 15 years of experience in populationbased cancer epidemiology. He trained as a resident physician in Portugal where he specialized in Public completed Health, then his MS and completed his MS and Ph.D. in Epidemiology inthe Netherlands and Miami, FL, respectively, and completed two fellowships at the International Agency for Research on Cancer in France. His research interests primarily focus on cancer outcomes in Hispanic/Latino populations, and more recently, on Black/African-descent populations with an emphasis on revealing disparities in incidence, survival, and mortality masked by aggregating racial/ethnic groups. In 2009, he pioneered the monitoring of cancer incidence in Hispanic subgroups (Mexicans, Cubans, Puerto Ricans) in the U.S. based on individual-level data from Florida. Subsequently, he has studied cancer in large and diverse Hispanic populations in Mexico, Colombia, California, New York, and Texas. Additionally, he has worked to improve cancer surveillance methodology and strives to achieve the most accurate characterization of cancer patterns in Latinos, thereby presenting a far more complex picture of the so-called “Hispanic Paradox”. Dr. Pinheiro has over 50 peer-reviewed publications, 15 of them as the first author, with

University of Miami Miller School of Medicine Department of Public Health Sciences

more than 2000 citations to date. He has presented over 20 presentations in conferences on four different continents. Lastly, he has participated in NIH grant review panels for the Cancer Section and contributed to national reports and monograph initiatives from the National Cancer Institute, the American Cancer Society, and the Centers for Disease Control and Prevention. Dr. Pinheiro has served in the NIH study section CHSA 1 - Cancer Heart Sleep A. Tulay Koru-Sengul, Ph.D., is a Research Associate Professor in DPHS at UMMSM. She is a member in the Cancer Epidemiology and Prevention Clinical Protocol Program, Review Committee, the Data and Safety Monitoring Committee and a faculty biostatistician in the Biostatistics and Bioinformatics Core at Sylvester Comprehensive Cancer Center. She earned her Master’s degree in biostatistics from Johns Hopkins University, and both Master’s and Doctoral degrees in statistics from University of Pittsburgh. She held research positions at University of Pittsburgh and faculty appointments at the State University of New York at Buffalo, University of Saskatchewan and McMaster University in Canada. Along with her faculty appointments, she was the Director of the Statistical Consulting Laboratory in the Department of Biostatistics at the State University of New York at Buffalo, a Research Scientist at Saskatchewan Health Quality Council, and a faculty biostatistician in the Clinical Trials Methodology Group at Ontario Clinical Oncology Group in Canada. Her research interests include development and application of statistical methods for biological responses that vary in time and occasion, design and analysis of clinical trials, missing data analysis, and statistical methods for high dimensional medical data. Her current cancer research interests focus on the areas of health disparities in cancer diagnosis, prevention, screening, survival and other outcomes using large population-based databases. She

currently teaches Medical Biostatistics in the MPH, MD/MPH programs and activity mentors several graduate students, medical residents and fellows. Naresh Kumar, Ph.D., is an Associate Professor of Environmental Health in DPHS, Abess Center for Ecosystem Science and Policy, and Department of Geography and Regional Studies at the University of Miami. Dr. Kumar’s research and teaching are dedicated to prevent and manage environmental disease burden. A novel aspect of his research includes engaging communities in prevention measures through a personalized realtime environmental risk surveillance system. This system monitors and records environmental pollution in real-time and informs targeted users (such as asthmatic and COPD patients) about hazardous concentrations in real-time through cellphones and web. Dr. Kumar is the Co-PI of an EPA grant that aims to develop and validate novel methods of quantifying ambient air pollution at any given location and time by integrating satellite remote sensing and chemical transport models. He is the Co-PI of an NSF grant that has developed a cost-effective spatial sampling and survey methodology to screen populations for demographic and health characteristics. His research on air pollution and health has been featured in high profile media, such as Science Daily and Wall Street Journal. He currently teaches “Environmental Health” and “Methods of Environmental Epidemiology” in MD/MPH, MPH and Ph.D. programs. He serves as a reviewer for NIH and NSF, and other high impact journals, such as Environment Science and Technology, Environmental Health Perspective and Public Opinion Research. Dr. Kumar’s current research focuses on real-time personalized health risk surveillance, novel spatiotemporal methodologies that compute environmental disease burden, and on the quantification of meteorological conditions that mediate the health effects of air pollution. Other focuses include assessing the burden of disease and disability in

University of Miami Miller School of Medicine Department of Public Health Sciences

response to extreme weather, including hurricanes. He also is the Director of the first Master of Science in Climate and Health graduate program in the nation. Every year, Dr. Kumar leads a climate and health symposium that brings different stakeholders to address health effects of climate and extreme weather. Deukwoo Kwon, Ph.D., is a Research Assistant Professor in Biostatistics and Bioinformatics Shared Resource (BBSR) in DPHS and the Sylvester Comprehensive Cancer Center at UMMSM. He earned his Master’s degree in statistics and Ph.D. in statistics from Texas A&M University and worked at the National Cancer Institute for six years. Dr. Kwon worked on various epidemiologic studies including radiation exposure assessment, uncertainty analysis, and measurement error models in dose-response relationship at NCI. He joined Sylvester BBSR in October 2011. He has extensive experience conducting statistical analysis for various areas: statistical methods applied to clinical trials and epidemiologic studies related to cancer, novel approaches to statistical design and analysis of phase I and phase II clinical trials, survival analysis, longitudinal data analysis, Bayesian inference, and high-dimensional data analysis. He is a member of Protocol Review and Monitoring Committee at Sylvester Comprehensive Cancer Center. David Lee, Ph.D., is a Professor in DPHS at UMMSM. He also serves as Graduate Programs Director, overseeing MPH, MsPH, and epidemiology, and biostatistics. He has been He has been involved in the He has been involved in the mentoring of students including service on 25 dissertation committees and assisting students obtain F30/F31 support for their graduate studies. Dr. Lee is a chronic disease

FACULTY BIOGRAPHIES CONTINUED and occupational epidemiologist and has been continuously funded as Principal Investigator on various grants from the National Institutes of Health and the Centers for Disease Control and Prevention since 1993. He also serves as Principal Investigator for the Florida Cancer Data System, which is the second largest state cancer registry in the United States. Dr. Lee is lead or co-author on over 200 peerreviewed research articles. A strong emphasis on health disparity reduction is a crosscutting theme within his research portfolio. Additionally, students are active members of his research teams contributing to the 50+ student-led publications in leading biomedical journals including the American Journal of Public Health, Preventive Medicine, Cancer, Circulation, Diabetes Care, and the American Journal of Ophthalmology. Dr. Lee’s current research interests include: public health applications of mindfulness practices (e.g., yoga, meditation) for the prevention and management of chronic disease, enhancing the health of the U.S. workforce, population approaches toward the reduction of eye disease, and cancer surveillance and prevention. Dr. Lee completed a 4-year appointment to the NIH National Deafness and Other Communication Disorders Advisory Council. Howard Liddle, Ed.D., ABPP, is a Professor in DPHS and Director of the Center for Treatment Research on Adolescent Drug Abuse at UMMSM. As a psychologist, Dr. Liddle’s research focus is on the development, testing, implementation and dissemination of family based treatment for adolescent substance abuse and delinquency. His research in this area has been funded by a variety of NIDA grants since 1985. Multidimensional Family Therapy (MDFT) is the most researched family-based treatment in the adolescent substance abuse specialty, and MDFT studies and the clinical model are recognized nationally and internationally. MDFT has been

University of Miami Miller School of Medicine Department of Public Health Sciences

implemented and sustained in 100+ communities around the U.S. and in eight European countries. Recent and current projects include implementation grants that test the incorporation of a cross system juvenile justice -- substance abuse and HIV prevention intervention in the Connecticut state justice system, and a controlled trial testing MDFT in a juvenile justice day treatment school setting. Dr. Liddle’s work has been recognized with career research awards from the American Association for Marriage and Family Therapy, the American Family Therapy Association, the Hazelden Foundation, and the American Psychological Association. The MDFT approach is practiced in clinics around the United States. As a result of a successful, multisite, multinational controlled trial of MDFT in five European countries, MDFT is now practiced in these and other European nations. Kathryn E. McCollister, Ph.D., is an Associate Professor and Health Economist and is the Director of the Division of Health Services Research and Policy in DPHS at UMMSM. Dr. McCollister’s primary research focuses on economic evaluation (cost-effectiveness effectiveness treatment and benefit-cost analyses) of treatment interventions for individuals with substance use disorders, including criminal offenders and pregnant/parenting women. She has also conducted economic studies of a family-based HIV and drug use preventive intervention for Hispanic youth, an early childcare center obesity prevention program, and schoolbased primary care health centers among disadvantaged communities in Miami-Dade County. Dr. McCollister’s secondary area of research involves estimating the burden of disease and disparities in health-related quality of life among occupational groups and the visually impaired. Dr. McCollister has served as the Principal Investigator on projects funded by the National Institutes of Health (NIH) and the

Robert Wood Johnson Foundation. She has also collaborated on numerous projects funded by the NIH, Substance Abuse and Mental Health Services Administration, Office of Ju venile Ju stice and Delinquency Prevention, Centers for Disease Control and Prevention, Centers for Medicare and Medicaid Services, and the State of Florida. Dr. McCollister is currently the Co-Director of the Methodology Core of the NIDA-funded Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH), led by colleagues at Weill Cornell Medical College. In addition to conducting research, Dr. McCollister teaches Health Economics in the MPH and MD/MPH programs in DPHS. She also serves as a grant peer reviewer for the NIH and as an editorial board member for the Journal of Substance Abuse Treatment. Dr. McCollister is a leading expert in the health economics of treatment strategies for substance use disorders, and one of the lead economists on the multistate, National Institute on Drug Abuse-funded Helping End Addiction Long-term (HEALing) Communities initiative to implement and test evidence-based practices for reducing fatal opioid overdoses and related consequences of the national opioid epidemic. Dr. McCollister developed estimates of the societal cost of crime for 13 unique criminal offenses t hat have been incorporated into national data sets (Global Appraisal of Individual Needs) and applied in numerous studies to calculate reduced social and criminal justice system costs of interventions for substance use disorders and crime prevention programs. Additionally, she contributed to the development and application of standardized costing surveys based on the Drug Abuse Treatment Cost Analysis Program (DATCAP) to capture patient and family/caregiver costs attributable to self- or family-member participation in substance use disorder treatment. Dr. McCollister was also one of the lead investigators on the cost-effectiveness analysis of the first U .S.-based, m ulti-site, r andomized comparative effectiveness t rial o f p harmacotherapy for opioid use disorders, extended-release naltrexone (Vivitrol) versus buprenorphine-naloxone (Suboxone).

Clyde B. McCoy, Ph.D., is a professor in DPHS at UMMSM. He has established a successful career and international reputation in research, teaching and administration. He has been honored as a Distinguished Alumni at the University of Cincinnati, Norview High School,

and

Most

Outstanding

Faculty

Athletic

Representative by the American Football Foundation (served

the

Faculty

Athletic

Representative

1994-2012, President of the ACC 2009-2010, and a member of the University of Miami Sports Hall of Fame) and is proud to be a member of University of Miamiâ&#x20AC;&#x2122;s Iron Arrow and Phi Beta Delta, Honor Society for International Scholars. Dr. McCoyâ&#x20AC;&#x2122;s public health contributions include the following: He served as chair of the Department of Epidemiology and Public Health at UMMSM for more than a decade, Director of the Comprehensive Drug Research Center and Director of Health Services Research since 1974.

He has more

than 35 years of experience working with the State of Florida and its many departments particularly the Department of Health where he has been the Chair of the Biomedical Research Advisory Council as well as the Center for the Universal Research to Eradicate Disease. Dr. McCoy is founding member of the Florida Institute of Public Health and the Miami Dade Public Health Institute, which became the state-wide Florida Public Health Institute, of which he was a founding member and continues to serve today. He has served for many years as a member of the Resident Advisory Council for the Palm Beach Public Health Department; the only local department with a residency in preventive medicine. He was the inaugural recipient of

the

Senator

James

King

Leadership

Award

recognizing his many contributions to the Florida Department of Health and the State of Florida. McCoy

founding

member

the

Dr.

Special

Populations Scholars Group of NIDA, including the National Hispanic Science Network (NHSN) and the American Indian/ Alaska Native (AI/AN) Special Populations Group, and still serves on both groups.

University of Miami Miller School of Medicine Department of Public Health Sciences

FACULTY BIOGRAPHIES CONTINUED Shari Messinger, Ph.D., is an Associate Professor in the Division of Biostatistics and Director of Biostatistics Collaboration and Consulting Core in DPHS at UMMSM. She additionally serves a Director of the Research Design and Biostatistics Program of the Miami CTSI. Dr. Messinger has previously served as Biostatistics Director for the Diabetes Research Institute and Director of Biostatistics for the University of Miami General Clinical Research Center, and eventually the Schoolsupported Clinical Research Center. Dr. Messinger joined the faculty at the University of Miami in 2002, after earning her Doctorate in Biostatistics from the University of Michigan. She additionally holds a Master’s degree from the University of Florida in Industrial and Systems Engineering specializing in Operations Research and Health Systems Engineering. Her research includes investigations of serum microRNA as biomarkers for T1DM. Other research has been focused in islet transplantation, both in determining factors resulting in transplantable islet preparations as extensions into clinical practice of transplantation by identifying factors that are prognostic of eventual graft survival. She additionally collaborates in research investigations involving epidemiologic and intervention studies addressing primary and secondary prevention for persons at risk and living with HIV. Dr. Messinger regularly teaches courses in the Biostatistics and Epidemiology programs, as well as holds lectures to educate the research community on statistical issues related to clinical and translational research. Dr. Messinger serves on the Committee on Applied Statisticians of the American Statistical Association, the Biostatistics Epidemiology Research Design Significant Interest Group of the CTSA Consortium, the Methods and Processes Direct Task Force of the CTSA Consortium, the Clinical Transplant Islet Registry Publication and Presentation Committee, and is an active member of the Biometric Society.

University of Miami Miller School of Medicine Department of Public Health Sciences

Tatiana Perrino, Psy.D., is an Associate Professor in DPHS at UMMSM. She is a clinical psychologist who has dedicated her career to the promotion of health in minority and socio-economically disadvantaged communities. Dr. Perrino’s research and community work focus on the prevention of mental, emotional and behavioral problems among youth, especially depression, as well as the critical role that families can play in health promotion. She has worked in several health research areas, including drug abuse, HIV, obesity, and depression, and is a long-time member of the Society for Prevention Research, the American Psychological Association, and the American Public Health Association. Dr. Perrino is instructor and advisor to students in the Master of Public Health program and the Ph.D. in Prevention Science and Community Health, and Epidemiology programs. She teaches two courses in DPHS: Health Education & Behavior and Determinants of Health and Disparities across the Life Course. Health Guillermo “Willy” Prado, Ph.D., is the Dean of the University of Miami’s Graduate School, Professor and the Director of the Division of Prevention Science and Community Health in DPHS at UMMSM. Prado’s research focuses on the prevention of risky health behaviors, including drug use, unsafe sexual behavior, lack of physical activity, and poor dietary intake, associated with the top leading causes of morbidity and mortality in adolescents, and Hispanic youth in particular. His program of research on Hispanic adolescent health has been continuously funded by the NIH since the first year of his doctoral

program when he received a R03. Since then, he has been PI, Co-PI, co-investigator, or senior mentor of HIV, substance abuse, and obesity prevention studies totally approximately $80 million of NIH and CDC funding. He is currently the PI of two NIH funded R01s – one in drug abuse and HIV prevention and the second in obesity prevention. Additionally, Dr. Prado is currently the Director of the Training and Mentoring Core of the NIH funded U54 Center for Latino Health Research Opportunities. Dr. Prado’s research has been recognized by numerous organizations, including the Society for Prevention Research, the Society for Research on Adolescence, and the National Hispanic Science Network on Drug Abuse. He was also selected by the Miami Herald as one of the Top 20 Business Leaders and Innovators in South Florida under the age of 40 in its inaugural class for his research and community work in the areas of HIV and substance use among Hispanic families. In 2017, he was selected as a “Research Exemplar” by the Washington University Center for Clinical and Research Ethics and he received the Mentoring and Training award from the Society for Prevention Research. Prado has served for six years on NIH study section, was the Associate Editor for Prevention Science, was the 2013 Chair of the Society for Prevention Research’s 21st Annual Conference and the Co-Chair of the 2013 Meeting of the National Hispanic Science Network. In 2018, Prado was nominated and asked to join the Board of Directors of Research America. Other Board members include Drs. Georges Benjamin (Executive Director of the American Public Health Association), Victor Dzau (President, National Academy of Science), and Rush Holt (CEO, American Association for the Advancement of Science). Dr. Prado and his colleagues developed Familias Unidas, the parenting intervention for Hispanic youth and their parents, has been evaluated in multiple NIH funded trials, and is now being disseminated in multiple states across the country as well as in communities across Ecuador and Chile. Families in these communities have seen significant reductions in substance use and sexual risk behaviors. Two adaptations of this evidence-based intervention are now being evaluation via ongoing NIH studies: an obesity prevention adaption and an online adaption.

University of Miami Miller School of Medicine Department of Public Health Sciences

Isildinha Reis, Ph.D., is a Research Professor in the Division of Biostatistics of DPHS at UMMSM and in the Biostatistics and Bioinformatics Core Shared Resource at the Sylvester Comprehensive Cancer Center. Dr. Reis is a member of the Sylvester’s Data and Safety Monitoring Committee (DSMC) and an alternative member of the Protocol Review Committee (PRC). She is also an affiliated-member of the Biobehavioral Oncology and Cancer Epidemiology (BOCEprogram and the BCRdesignated statistician for both the Viral Oncology (VO) and the Molecular Targets and Developmental Therapeutics (MTDT) research programs as well as the breast cancer SDG. Dr. Reis earned her master’s degree in statistics from the University of São Paulo, Institute of Mathematics and Statistics, in 1989 and her DrPH in biostatistics in 1996 from the University of California at Los Angeles’ School of Public Health. Dr. Reis began her career as a statistician in a pharmaceutical company in São Paulo, Brazil in 1981 and then held a faculty position in the Biostatistics Division of the School of Public Health at the University of São Paulo for 10 years. Dr. Reis joined the University of Miami and Sylvester in 1999 as a Research Assistant Professor in the former Department of Epidemiology and Public Health and was promoted to Research Associate Professor in 2006. Dr. Reis served as Director of the Biostatistics Division of the Sylvester Biostatistics and Bioinformatics Core Shared Resource from 2012 to 2015. As a faculty biostatistician, Dr. Reis brings important statistical expertise to research projects at the University of Miami. Her ongoing collaboration with numerous Sylvester clinicians and research scientists includes clinical trials, basicscience research and translational investigations. Dr. Reis’ areas of special interest include survival analysis, repeated measures analysis, and statistical methods for planning and analyzing oncology clinical trials and clinical epidemiology studies. Dr. Reis regularly teaches a onesemester graduate course in survival analysis.

FACULTY BIOGRAPHIES CONTINUED J. Sunil Rao, Ph.D., is Interim Chair, Professor and Director of the Division of Biostatistics in DPHS at UMMSM. Previously, Dr. Rao was Professor of Biostatistics at Case Western Reserve University in Cleveland, Ohio. Dr. Rao’s research interests include high dimensional model selection, mixed model selection, predictive modeling, sparse bump hunting and development of statistical methods in cancer genomics. Dr. Rao teaches Generalized Linear Models in the M.S. and Ph.D. programs in Biostatistics. Dr. Rao has developed seminal work together with Dr. Ishwaran on high dimensional model selection using spike and slab priors, as well as some of the pioneering work in mixed model selection using fence method methodology. Additionally, he developed the observed best predictor (OBP) for small area estimation (SAE). He has also made significant advances in the area of personalized predictions using classified mixed model prediction (CMMP), which aligns with a precision medicine paradigm. Currently, Dr. Rao is developing new methods for bridging precision medicine and health disparities. His areas of application include cancer genomics and epigenomics, pharmacogenomics, subgroup identification and cancer health disparities. For external activities, Dr. Rao serves and has served on many editorial boards of statistics and bioinformatics journals, and served on various NIH grant review panels. He is also a fellow of the American Statistical Association.

University of Miami Miller School of Medicine Department of Public Health Sciences

Seth J. Schwartz, Ph.D., is a Professor in DPHS at UMMSM. He has a master’s degree in family and child sciences from Florida State University and a Ph.D. in developmental psychology from Florida International University. Dr. Schwartz’s research program focuses on the interface among identity processes (including personal goals and values, acculturation, sexual identity, family relationships, health risk outcomes, and well-being. His research focuses on adolescents and emerging adults, particularly those from immigrant or minority backgrounds and those from cultural contexts characterized by rapid social change. He has 225 peer reviewed publications and is the Senior Editor of the Handbook of Identity Theory and Research and of the forthcoming Handbook of Acculturation and Health. He has also been principal investigator of three NIH-funded projects Dr. Schwartz is President of the Society for the Study of Emerging Adulthood, Director of the Ph.D. Program in Prevention Science and Community Health, and a member of the NIH Social Psychology, Personality, and Intergroup Process review panel. He was the Distinguished Alumnus and Tyner Eminent Lecturer at the Florida State University College of Human Sciences. He also maintains several international collaborations in the areas of personal and cultural identity, health risk behavior, and well-being. Sara M. St. George, Ph.D., is an Assistant Professor in Prevention and Community Health Division in DPHS at UMMSM. She received her Ph.D. in Clinical-Community Psychology from the University of South Carolina and has expertise in pediatric obesity and its associated

behaviors, including physical activity, sedentary behavior, and diet. Her research interests include developing and testing theoreticallybased obesity prevention interventions which integrate multiple influential systems (e.g., family and peers) to promote positive health behaviors in ethnic minority adolescents. Throughout her graduate training, Dr. St. George developed the beginnings of an independent program of clinical research in pediatric obesity prevention and health promotion funded by a diversity supplement grant (NIH R01 DK 067615-02S1) and a pre-doctoral fellowship (NIH F31 HD 066944). This work lead to her receiving the Outstanding Dissertation Award from the Society of Behavioral Medicine. She was recently awarded a NIH K01 early career investigator award to continue to build from and expand her program of research. The goals of this study are to develop and pilot test a family-based intervention that combines the web and smartphone technology for increasing physical activity, decreasing sedentary behavior, and improving quality dietary intake in Hispanic adolescents. Dr. St. George is affiliated with both the Sylvester Comprehensive Cancer Center and the Center on Aging. She currently teaches Qualitative Research Methods in the Master’s and Ph.D. programs within DPHS. José Szapocznik, Ph.D., is a Professor in DPHS at UMMSM. He is Chair Emeritus of the Department of Public Health Sciences, Director of the Center for Family Studies, and Honorary Founding Director of the University of Miami-based Miami Clinical Translational. He has received over $120 million in NIH funding and had over 270 scholarly publications. Szapocznik has a profound interest in the role of context in development, behavior and health outcomes, dedicating his career to studying culture, family, neighborhood and the built environments as important contexts influencing minority populations. He pioneered the national effort to prevent and treat adolescent drug abuse and related behavior problems in Hispanic youth, developing and testing familyUniversity of Miami Miller School of Medicine Department of Public Health Sciences

He has based, evidence-based approaches. also been a pioneer in the young field of the between the human built relationship environment and health outcomes, establishing a broadly interdisciplinary, university-wide team. As Contact PI of one of 13 NIDA-funded Nodes of the National Drug Abuse Treatment Clinical Trials Network (CTN), he has been a leader in the national initiative to translate effective drug abuse treatments into clinical practice by engaging the Network’s medical, community primary care and specialty drug treatment sites clinical trials. Dr. in conducting randomized Szapocznik has held a number of policy advisory roles including membership in the NIH National Advisory Councils for NIMH, NIDA, NIMHD, and the SAMSHA Center for Substance Abuse Prevention; and was a founding member and the first behavioral scientist to be appointed to the NIH-wide AIDS Program Advisory Committee (now the National Advisory Council for the NIH Office of AIDS). He served on Search Committees for the Directors of the FDA, NIMH, NIDA (3 times), and both SAMSHA Centers for Substance Abuse Treatment and Prevention. Lily Wang, Ph.D., is an Associate Professor in DPHS at UMMSM. She is affiliated with the Sylvester Comprehensive Cancer Center and the John P. Hussman Institute for Human Genomics (HIHG). She is also the Co-Director of the HIHG Statistical and Bioinformatics Consulting Core in the HIHG Center for Genetic Epidemiology and Statistical Genetics. Previously, she was a tenured Associate Professor of Biostatistics at Vanderbilt University School of Medicine. Her research interest is to develop effective statistical models for the analysis of high-throughput genomics datasets. Her recent work includes development of mixed effects models for pathway-based analysis of gene expression datasets and genome-wide association studies. Over the past 11 years, Dr. Wang has also collaborated with clinical and basic science researchers on a variety of projects ranging from basic science high-throughput genomics to clinical trials. 39

Get To Know Us Department of Public Health Sciences Designed by Amanda Torres Revision 04/24/2019

ACTIVELY WORKING INTERNATIONALLY, NATIONALLY AND LOCALLY TO PROMOTE PUBLIC HEALTH AND REDUCE THE BURDEN OF DISEASE.

WWW.PUBLICHEALTH.MED.MIAMI.EDU WWW.GRADUATESTUDIES.PUBLICHEALTH.MED.MIAMI.EDU University of Miami Public Health Sciences @UMPublicHealth @umpublichealth

Department of Public Health Sciences

Ph: 305-243-9105

1120 NW 14th Street, CRB 918 Miami, FL 33136 40